Emfo, LLC Checkpoint Therapeutics, Inc. Transaction History

Emfo, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$0.97 - $1.77 $4,850 - $8,850	-5,000 Reduced 2.55%	191,250 $197,000
Q4 2021 Jan 27, 2022	SELL	$2.68 - $4.46 $126,496 - $210,512	-47,200 Reduced 19.39%	196,250 $610,000
Q3 2021 Oct 26, 2021	SELL	$2.5 - $3.53 $1,750 - $2,471	-700 Reduced 0.29%	243,450 $803,000
Q2 2021 Jul 20, 2021	BUY	$2.36 - $3.2 $576,194 - $781,280	244,150 New	244,150 $720,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $234M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Emfo, LLC, based on Form 13F filings with the SEC.

Stay updated on Emfo, LLC with notifications on news.